Joseph P. Hagan

Insider Reports History

Entity
Individual
Location
3344 N. Torrey Pines Court, Suite 200, La Jolla, CA
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph P. Hagan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Director Common Stock 12K $135K $11.26 May 19, 2023 Direct
Regulus Therapeutics Inc. Chief Executive Officer, Director Common Stock 57.1K $68K $1.19 Jan 18, 2024 Direct
Regulus Therapeutics Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 990K May 20, 2024 Direct
Zosano Pharma Corp Director Stock Option (Right to Buy) 30K Jun 10, 2021 Direct
Zosano Pharma Corp Director Common Stock 22.5K Jun 10, 2021 Direct
Aurinia Pharmaceuticals Inc. Director Restricted Stock Units 0 May 18, 2023 Direct

Insider Reports Filed by Joseph P. Hagan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. May 20, 2024 1 $0 4 May 21, 2024 Chief Executive Officer, Director
RGLS Regulus Therapeutics Inc. Jan 18, 2024 1 -$17.4K 4 Jan 18, 2024 Chief Executive Officer, Director
RGLS Regulus Therapeutics Inc. Jan 12, 2024 2 $0 4 Jan 17, 2024 Chief Executive Officer, Director
RGLS Regulus Therapeutics Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 President and CEO, Director
AUPH Aurinia Pharmaceuticals Inc. May 18, 2023 3 -$2.88K 4 May 23, 2023 Director
RGLS Regulus Therapeutics Inc. Jan 11, 2023 1 $0 4 Jan 17, 2023 President and CEO, Director
AUPH Aurinia Pharmaceuticals Inc. May 18, 2022 2 $0 4 May 20, 2022 Director
RGLS Regulus Therapeutics Inc. May 10, 2022 1 $0 4 May 11, 2022 President and CEO, Director
RGLS Regulus Therapeutics Inc. Jan 12, 2022 2 $21.5K 4 Jan 26, 2022 President and CEO, Director
AUPH Aurinia Pharmaceuticals Inc. Jan 3, 2022 4 -$700K 4 Jan 4, 2022 Director
AUPH Aurinia Pharmaceuticals Inc. Jun 14, 2021 1 $0 4 Jun 16, 2021 Director
ZSAN Zosano Pharma Corp Jun 10, 2021 2 $0 4 Jun 14, 2021 Director
RGLS Regulus Therapeutics Inc. May 17, 2021 1 -$3.73K 4 May 17, 2021 President and CEO, Director